RE:RE:EnWave’s Partner in Cannabis Space Takes Giant LeapThe latest smallcaps report 10-may reported this on Sutro:
The powderREV machine for Sutro Biopharma, a pharmaceutical company based in San Francisco, is scheduled to be finished first. EnWave recently successfully conducted a pre-factory acceptance test. A factory acceptance test is currently ongoing. Once finished, this should trigger a go/no-go decision from Sutro to move the commercial scale REV machine from EnWave’s Vancouver facilities to Sutro’s San Francisco facilities for commercial startup in 2018.
If this REV machine is successful with the production of Sutro’s products, the company will immediately go into commercial production, as its ingredient does not require FDA approval. In that scenario, Sutro Biopharma would pay EnWave a royalty based on the production of its pharmaceutical ingredient.